CHRISTINE MOORE: Open Payments
NPI 1407893431 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,253 in 16 payments from 11 companies in 2025. Trend: 2023 $605 · 2024 $755 · 2025 $1,253
Food & beverage: $1,253
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $237 |
| Actelion Pharmaceuticals US, Inc. | 1 | $148 |
| Janssen Scientific Affairs, LLC | 1 | $125 |
| Lilly USA, LLC | 1 | $124 |
| Corcept Therapeutics | 1 | $124 |
| Neurocrine BioSciences, Inc. | 1 | $116 |
| Novo Nordisk Inc | 1 | $116 |
| Insmed, Inc. | 1 | $106 |
| AstraZeneca Pharmaceuticals LP | 1 | $96 |
| MERZ NORTH AMERICA, INC. | 2 | $48 |
Products named: UPTRAVI, TREMFYA, MOUNJARO, Korlym, INGREZZA, Ozempic, BOTOX, Arikayce.
Industry payments across FL — which companies pay providers there.
